IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BALOTTA, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.694
NA - Nord America 7.034
AS - Asia 5.271
SA - Sud America 597
AF - Africa 171
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 7
Totale 21.811
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.706
GB - Regno Unito 3.427
CN - Cina 1.827
SG - Singapore 1.738
DE - Germania 1.420
IT - Italia 1.089
SE - Svezia 672
RU - Federazione Russa 535
BR - Brasile 443
HK - Hong Kong 431
CA - Canada 279
TR - Turchia 277
IE - Irlanda 257
UA - Ucraina 253
IN - India 249
NL - Olanda 243
FR - Francia 242
KR - Corea 214
FI - Finlandia 173
VN - Vietnam 152
EU - Europa 112
ID - Indonesia 101
PL - Polonia 77
CO - Colombia 59
CI - Costa d'Avorio 55
BE - Belgio 53
JP - Giappone 50
GR - Grecia 48
AR - Argentina 40
AT - Austria 38
TW - Taiwan 33
AU - Australia 32
ZA - Sudafrica 32
MX - Messico 29
ES - Italia 28
BD - Bangladesh 27
DK - Danimarca 25
IQ - Iraq 22
PK - Pakistan 21
MA - Marocco 20
BG - Bulgaria 18
CH - Svizzera 18
EC - Ecuador 17
UZ - Uzbekistan 15
RO - Romania 14
AE - Emirati Arabi Uniti 13
IR - Iran 13
NO - Norvegia 13
PH - Filippine 13
PT - Portogallo 13
SA - Arabia Saudita 10
TH - Thailandia 10
VE - Venezuela 10
CL - Cile 9
ET - Etiopia 9
OM - Oman 9
GH - Ghana 6
IL - Israele 6
MY - Malesia 6
NG - Nigeria 6
PE - Perù 6
BO - Bolivia 5
CZ - Repubblica Ceca 5
JO - Giordania 5
KE - Kenya 5
KZ - Kazakistan 5
LV - Lettonia 5
MK - Macedonia 5
NZ - Nuova Zelanda 5
TN - Tunisia 5
AZ - Azerbaigian 4
DZ - Algeria 4
EG - Egitto 4
JM - Giamaica 4
LB - Libano 4
PY - Paraguay 4
SL - Sierra Leone 4
TZ - Tanzania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
BY - Bielorussia 3
HU - Ungheria 3
KW - Kuwait 3
LT - Lituania 3
LU - Lussemburgo 3
NP - Nepal 3
TT - Trinidad e Tobago 3
UG - Uganda 3
UY - Uruguay 3
AM - Armenia 2
CM - Camerun 2
CR - Costa Rica 2
CY - Cipro 2
HR - Croazia 2
MW - Malawi 2
NI - Nicaragua 2
RS - Serbia 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
SZ - Regno dello Swaziland 2
Totale 21.895
Salva come PNG Salva come JPEG
Città #
Southend 3.211
Singapore 906
Frankfurt am Main 758
Ashburn 591
Chandler 561
Seattle 488
Milan 445
Hong Kong 415
Fairfield 390
Beijing 357
Wilmington 319
Princeton 291
Dublin 256
Woodbridge 239
Houston 227
Dallas 222
Council Bluffs 198
Ann Arbor 192
Jacksonville 160
Dearborn 158
Redmond 145
Toronto 143
Los Angeles 134
Cambridge 131
Santa Clara 128
Nanjing 120
Boardman 107
Bengaluru 103
Mountain View 102
Des Moines 95
Ottawa 95
Guangzhou 92
Sakarya 92
New York 83
Serra 78
Buffalo 77
Columbus 77
The Dalles 76
Moscow 73
San Jose 73
Jakarta 71
Phoenix 71
Warsaw 68
Hanover 67
Shanghai 64
Shenyang 62
Andover 57
Jinan 57
Abidjan 55
Somerville 54
Rome 50
Brussels 46
Bogotá 44
Helsinki 44
Istanbul 43
Nuremberg 43
Redwood City 43
Cangzhou 42
São Paulo 40
Tokyo 40
Hefei 39
Munich 39
Dong Ket 38
Changsha 36
Berlin 35
Hebei 35
Athens 33
Falls Church 32
Hanoi 32
Ho Chi Minh City 32
San Diego 32
Zhengzhou 32
Pisa 31
Mumbai 29
Tianjin 27
Grafing 25
Nanchang 25
Eitensheim 24
Hangzhou 23
Kunming 23
Jiaxing 22
Turin 22
Fuzhou 21
Margão 20
Seoul 20
Fremont 19
Silver Spring 18
Vienna 18
Bitonto 17
Nürnberg 15
Zhongli District 15
Brasília 14
London 14
Piscataway 14
Rio de Janeiro 14
Washington 14
Belo Horizonte 13
Shenzhen 13
Taipei 13
Wuhan 13
Totale 14.420
Salva come PNG Salva come JPEG
Nome #
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 515
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μl in Europe and North America: A pooled cohort observational study 417
Contribution of transgender sex workers to the complexity of the HIV-1 epidemic in the metropolitan area of Milan 409
Recombination analysis and structure prediction show correlation between breakpoint clusters and RNA hairpins in the pol gene of human immunodeficiency virus type 1 unique recombinant forms 343
Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection 318
Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by stromal-derived factor 1 chemokine gene polymorphism analysis 305
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 288
Prevalence of HIV-1 resistant strains in recent seroconverters 284
Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region : outcome after treatment in recently infected individuals 278
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 263
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts : Data from the Icona Foundation Cohort 262
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 262
HIV-1 A1 subtype epidemic in Italy originated from Africa and Eastern Europe and shows a high frequency of transmission chains involving intravenous drug users 254
Human immunodeficiency virus (HIV) phenotype and interleukin-2/ interleukin-10 ratio are associated markers of protection and progression in HIV infection 249
Evidence for type 2 cytokine production and lymphocyte activation in the early phases of HIV-1 infection 249
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 247
Role of CCR5, CCR2 and SDF-1 gene polymorphisms in a population of HIV-1 infected individuals 246
Local epidemics gone viral : evolution and diffusion of the Italian HIV-1 recombinant form CRF60_BC 246
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 245
Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy 244
Genomic characterisation and phylogenetic analysis of SARS-COV-2 in Italy 242
Changing patterns in HIV-1 non-B clade prevalence and diversity in Italy over three decades 235
Minor Mutations in HIV-Protease at Baseline and Appearance of Primary Mutation 90M in Patients Failing Their First Protease-Inhibitor Antiretroviral Regimens 217
High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype 216
Evidence of differential selection of HIV-1 variants carrying drug-resistant mutations in seroconverters 214
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 214
Transmitted HIV Type 1 drug resistance and Non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy 210
The global spread of HIV-1 subtype B epidemic 209
Telbivudine in the treatment of chronic hepatitis B : experience in HIV-1 infected patients naïve for antiretroviral therapy 206
Transmission of Resistant HIV-1 Variants and Epidemiological Chains in Italian Newly Diagnosed Individuals 206
Cellular HIV-1 DNA levels in drug sensitive strains are equivalent to those in drug resistant strains in newly-diagnosed patients in Europe 205
Non-AIDS defining cancers in the D:A:D Study-time trends and predictors of survival : a cohort study 202
AIDS in a long-term HIV-1-infected patient with a stable high CD4+ cell count and conserved CD4+CD45RO+ subpopulation 199
Discontinuation of initial antiretroviral therapy in clinical practice : Moving toward individualized therapy 197
Molecular tracing of SARS-CoV-2 in Italy in the first three months of the epidemic 195
Epidemiological spread of drug-resistant HIV-1 strains 193
Susceptibility to PNU-140690 (Tipranavir) of human immunodeficiency virus type 1 isolates derived from patients with multidrug resistance to other protease inhibitors 192
HIV-1 Subtype F1 Epidemiological Networks among Italian Heterosexual Males Are Associated with Introduction Events from South America 191
Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic 191
Chemokine production in HIV-seropositive long-term asymptomatic individuals 183
Virologic and immunologic markers of disease progression in pediatric HIV infection 182
Evidence of differential selection of HIV-1 variants carrying drug-resistant mutations in seroconverters 179
Viral load, viral phenotype modification, zidovudine susceptibility and reverse transcriptase mutations during the first 6 months of zidovudine monotherapy in HIV-1-infected people 179
Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, Belgium 179
Predictors of cytomegalovirus disease, natural history and autopsy findings in a cohort of patients with AIDS 178
Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategy 176
Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003-2012 decade in Italy 175
Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1-infected Italian patients with virologic failure 174
Limited cross-border infections in patients newly diagnosed with HIV in Europe 174
Identification of a new HIV-1 BC circulating recombinant form (CRF60_BC) in Italian young men having sex with men 172
The prognostic value to predict virological outcomes of 14 distinct systems used to interpret the results of genotypic HIV-1 drug resistance testing in untreated patients starting their first HAART 171
Identification of a possible ancestor of the subtype A1 HIV-1 variant circulating in the Former Soviet Union 170
Transmission of drug-resistant HIV-1 in Europe remains limited to single classes 170
Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe : Implications for clinical management 169
Comparable biological and molecular determinants in HIV type 1-infected long-term nonprogressors and recently infected individuals 169
Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection 168
HIV type 1 phenotype correlates with the stage of infection in vertically infected children 168
Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients. 167
A Simple model of HIV epidemic in Italy: The role of the antiretroviral treatment 167
Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure 165
Patterns of transmitted HIV drug resistance in Europe vary by risk group 164
Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient 163
Variability in the interpretation of transmitted genotypic HIV-1 drug resistance and prediction of virological outcomes of the initial HAART by distinct systems 160
Subtype assignment and phylogenetic analysis of HIV type 1 strains in patients from Swaziland. 159
Patterns of in vitro anti-human immunodeficiency virus type 1 antibody production in long-term nonprogressors 159
Differences in the frequency of minor substitutions between HIV-1 subtypes and their potential impact on the genetic barrier for resistance to protease inhibitors 158
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives : Data from the ICONA cohort 156
Prevalence of HIV-1 primary drug resistance in seroconverters of the ICoNA cohort over the period 1996-2001 155
Pentoxifylline improves cell-mediated immunity and reduces human immunodeficiency virus (HIV) plasma viremia in asymptomatic HIV-seropositive persons 155
Local and global spatio-temporal dynamics of HIV-1 subtype F1 155
Evolution of Resistance-Associated Variants of All-Oral Direct-Acting Antiviral Therapy of Hepatitis C in a Clinical Setting 155
Transmission of drug-resistant HIV-1 is stabilizing in Europe 153
HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics 152
High frequency of man having sex with man with unknown duration of infection in epidemiological networks involving primary resistance in HIV 1 naive individuals 151
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 151
Long-term resistance to HIV infection in vertical HIV infection: cytokine production, HIV isolation, and HIV phenotype define long-term resistant hosts 148
An outbreak of HIV-1 subtype G among Italian injecting drug users 147
Evolution of HIV-1 transmitted drug resistance in Italy in the 2007–2014 period : a weighted analysis 144
Processivity and drug-dependence of HIV-1 protease : determinants of viral fitness in variants resistant to protease inhibitors 142
Low prevalence of primary mutations associated with drug resistance in antiviral-naive patients at therapy initiation 140
Antiinflammatory action of salicylates: aspirin is not a prodrug for salicylate against rat carrageenin pleurisy 139
Phylogenetic analysis provides evidence of interactions between Italian heterosexual and South American homosexual males as the main source of national HIV-1 subtype C epidemics 137
Durability of Humoral Responses after the Second Dose of mRNA BNT162b2 Vaccine in Residents of a Long Term Care Facility 137
Chemotactic factor and P15E-related chemotaxis inhibitor in human melanoma cell lines with different macrophage content and tumorigenicity in nude mice 135
Global dispersal pattern of HIV-1 CRF01_AE : a genetic trace of human mobility related to heterosexual activities centralized in South-East Asia 135
Overview on HIV-1-related drug resistance: from theory to clinical practice 133
Response to antiretroviral therapy in a patient with an uncommon codon 69 insertion in the human immunodeficiency virus type 1 reverse transcriptase 132
Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms : data from seroconverters in the CASCADE collaboration from 1987 to 2003 131
Augmentation of monocyte chemotaxis by 1 alpha,25-dihydroxyvitamin D3. Stimulation of defective migration of AIDS patients 131
Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection 131
Impact of mutations conferring reduced susceptibility to lamivudine on the response to antiretroviral therapy 131
An outbreak of HIV-1 BC recombinants in Southern Italy 130
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy : Data from the Icona Foundation cohort 130
Clinical and immunological aspects of HIV infection in drug addicts 129
Plasma viremia and virus phenotype are correlates of disease progression in vertically human immunodeficiency virus type 1-infected children 129
Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages 125
Persisting HIV-1 replication triggered by acute hepatitis A virus infection 124
HIV-1 subtypes and circulating recombinant forms (CRFs) from HIV-infected patients residing in two regions of central and southern Italy 124
Genotypic resistance tests for the management of the HIV-infected patient with non-B viral isolates 124
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe 124
Totale 19.171
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.856
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.364 0 0 0 0 0 151 135 148 257 129 425 119
2021/20221.736 149 90 65 78 128 97 153 150 225 193 126 282
2022/20232.091 258 212 174 245 218 369 43 121 289 22 90 50
2023/20241.626 34 100 66 48 274 102 142 161 69 165 190 275
2024/20253.532 208 356 127 339 291 145 200 356 211 294 279 726
2025/20263.198 661 323 636 508 618 452 0 0 0 0 0 0
Totale 22.814